What are the dangers of arbutin acid?

Before analyzing its safety profile, let’s recall why arbutin has become a reference active ingredient. Mainly used for its depigmenting effect, it works by inhibiting tyrosinase, the enzyme responsible for melanin production. Beyond this ability to reduce pigmentation spots, studies also attribute antioxidant and anti-inflammatory properties to arbutin, making it a versatile active for maintaining skin radiance and an even complexion.

However, the chemical structure of alpha-arbutin is at the heart of toxicological concerns.

Indeed, arbutin is a hydroquinone glucoside. This means that it is composed of a hydroquinone molecule to which a glucose group is attached. While arbutin is permitted in cosmetics, hydroquinone itself has been strictly banned in Europe since 2001, except in controlled medical use, due to its toxicity and serious side effects. Hydroquinone is particularly suspected of being carcinogenic and mutagenic. The potential risk of arbutin therefore lies in its retro-conversion: breaking the chemical bond between glucose and hydroquinone would release the hydroquinone onto the skin.

However, the stability of arbutin in a cosmetic product is not absolute.

Several environmental factors can trigger its hydrolysis—and thus the release of hydroquinone—such as heat, pH (more specifically an acidic pH), and exposure to UV radiation. One study specifically examined the stability of arbutin under various stress conditions. The researchers tested 21 products using high-performance liquid chromatography (HPLC). One of the creams labeled as containing 1.61% arbutin already had, in its initial state, 0.12% free hydroquinone. In addition, intensive thermal degradation tests (up to 120°C for 6 hours) confirmed a release of hydroquinone from pure arbutin.

These results must, however, be interpreted with caution: the temperature of 120°C used to induce this decomposition is considered extreme.

For comparison, the stability and accelerated aging tests carried out by the cosmetics industry—which involve exposing a product to high heat for several weeks to simulate several years of storage—generally do not exceed 45°C to 50°C (113°F to 122°F). While the risk of thermal conversion therefore appears limited under normal conditions of use, caution is still required with regard to prolonged exposure to UV radiation, which can break down arbutin acid into hydroquinone and p-benzoquinone, an oxidizing agent.

The risk of transformation does not end with the stability of the vial; it continues during application.

In fact, our skin hosts billions of microorganisms that possess their own enzymes. Common bacteria in the skin flora, such as Staphylococcus epidermidis or Staphylococcus aureus, are capable of metabolizing arbutin. By secreting specific enzymes, they can break the glucose–hydroquinone bond directly at the surface of the epidermis. While this conversion could theoretically enhance skin-lightening efficacy, since hydroquinone is more potent, it also raises serious concerns about the actual, uncontrolled exposure of the body to this molecule, which is banned under cosmetic regulations.

In summary, although arbutin acid is a legal alternative to hydroquinone, its tendency to convert into other compounds calls for caution and continued research.

In addition to its potential conversion into hydroquinone, arbutin acid on the skin can cause undesirable reactions. Although these reactions remain relatively uncommon, various clinical reports mention redness, burning sensations, and tingling associated with the topical application of arbutin.

A Japanese clinical report specifically described the case of a 60‑year‑old female patient who developed a facial edematous erythema with itching after using a skin‑lightening cream. Patch tests confirmed a clear allergic reaction to arbutin, which persisted even at very low concentrations, around 0.3%, while the other ingredients in the product had no effect. Although such allergic cases are considered relatively rare in the scientific literature, they serve as a reminder that arbutin is a potentially sensitizing substance.

The warning signals related to arbutin acid are not subsiding. Although toxicological studies often focus on ingestion, their findings cannot be completely dismissed in cosmetology. The precautionary principle suggests that what is toxic when taken orally could, through prolonged cutaneous absorption, present similar risks. Arbutin in particular raises concerns about liver and brain toxicity.

Studies conducted on rats have shown that at very high doses (2,000 mg/kg), alpha-arbutin can cause an increase in liver enzymes and brain inflammation characterized by necrosis of epithelial cells in the cortex. Although these doses are far higher than those used in cosmetic applications, they reveal the cytotoxic potential of the molecule.

In addition, concerns about arbutin extend to the hormonal sphere. An in vitro study conducted on Leydig cells—the testicular cells responsible for testosterone production—showed that exposure to arbutin led to a significant inhibition of androgen secretion. At a concentration of 50 μM, the compound is even able to block the stimulating effects of luteinizing hormone, which is essential for reproductive function. Analyses showed that arbutin acts by downregulating the expression of several genes involved in hormone synthesis, such as Lhcgr, Hsd3b1, Cyp17a1 and Srd5a1.

Although these data come from cellular models rather than from applications on the skin, they highlight the need to remain cautious.

Given these data, the Scientific Committee on Consumer Safety (SCCS) has set strict thresholds to limit systemic exposure to arbutin acid. Since 2015, the recommendation has been to not exceed 2% alpha-arbutin in facial care products and 0.5% in body lotions. These limits are intended to ensure that, even if partial conversion to hydroquinone occurs on the skin, the absorbed amount remains below critical toxicity thresholds. However, the question of cumulative effects with regular use over several years remains a point of concern for dermatological research.

Although arbutin acid is effective for managing hyperpigmentation, its safety profile requires constant vigilance. Between its chemical instability and the warning signals emerging from toxicological research, its use cannot be considered entirely harmless.

• KIM D. H. & al. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity. Journal of Cosmetic Dermatology (2008).

• SHIN H. C. & al. Simultaneous determination of arbutin and its decomposed product hydroquinone in whitening creams using high-performance liquid chromatography with photodiode array detection: Effect of temperature and pH on decomposition. International Journal of Cosmetic Science (2015).

• OKUBO Y. & al. Contact dermatitis caused by arbutin contained in skin-whitening cosmetics. Contact Dermatitis (2016).

• BOO Y. C. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants (2021).

• KUSHWAH A. S. & al. Pharmacological aspects of a bioactive compound arbutin: A comprehensive review. Biointerface Research in Applied Chemistry (2023).

• GE R.-S. & al. Arbutin inhibits androgen biosynthesis by rat immature Leydig cells in vitro. Reproductive Toxicology (2023).

• Scientific Committee on Consumer Safety (SCCS). Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products (2023).

• KHAN M. & al. Acute and subacute toxicity study of α-arbutin: An in vivo evidence. Journal of Applied Toxicology (2025).